Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Can You Get Coronavirus a Second Time? Other Common Questions

Can You Get Coronavirus a Second Time? Other Common Questions

Covid-19 Disease Caused by the Novel Coronavirus (SARS-CoV-2) first appeared in December 2019 and has affected the whole world ever since. From then until March 2021, approximately 120 million Covid-19 cases were reported worldwide, and more than 90 million people managed to recover from this disease. But are people who have recovered from this disease at risk of becoming infected with the novel coronavirus (SARS-CoV-2) again and developing Covid-19?

According to the US Centers for Disease Control and Prevention (US-CDC) on 10 September 2020, there had been no confirmed report up to that date of a person being reinfected with SARS-CoV-2 within 3 months of infection.

Because of the lack of human data, rhesus monkeys were exposed to the same viral strain again 28 days after their initial infection, and no recurrent infection occurred.

However, on 21 September 2020, the European CDC published a report addressing SARS-CoV-2 reinfection.

Getting Coronavirus Disease a Second Time

Recurrent infections are observed with most respiratory viruses, including human coronaviruses. Reinfection with respiratory viruses may depend on:

  • A weak initial immune response or a weakening of that response,
  • Reinfection with another genotype / type,
  • Changes in the viral load of the viruses.

After the SARS-CoV-1 and MERS-CoV (Middle East Respiratory Syndrome Coronavirus) outbreaks, specific antibodies against the coronavirus were detected in survivors for up to 24 and 34 months, respectively. The negligible risk of a second exposure to these viruses has not allowed a clinical definition of immunity against reinfection.

The table below provides a summary of different respiratory viruses.

epidemiological comparison of respiratory infections influenza covid-19 sars mers

For coronaviruses that cause outbreaks, immunity has been shown to be a temporary condition lasting from a few months to a few years, and reinfection after natural and experimental infection has been reported. The immune response after a natural viral infection is thought to be incomplete, and reinfection is considered likely.

Currently, RNA and viral vector vaccines are among the Covid-19 vaccine platforms being tested, which are designed to elicit antibody and T-cell responses. Subunit vaccines, however, are more limited to antibody responses, eliminating the effect of active effector T cells and memory T cells.

What Do Recurrent Covid-19 and Repeat Positive PCR Tests Within 90 Days of Symptom Onset Mean?

Some publications have described cases with repeat positive SARS-CoV-2 PCR tests after negative tests and clinical recovery, or cases showing symptoms compatible with Covid-19. These cases were described within a period of up to 90 days after the acute illness and may reflect persistent / fluctuating viral shedding with persistent or relapsing (recurrent) clinical illness rather than true reinfection. Other viral infections or bacterial / fungal superinfections may also explain a concurrent episode of symptoms in some of these events in the presence of residual SARS-CoV-2 RNA. In addition, repeat weakly positive PCR results (cycle threshold (Ct) > 35) probably reflect non-replicating virus rather than a true active infection.

Furthermore, large datasets from China reported a median hospital stay of 22 days due to Covid-19. Median viral shedding in hospitalized cases was reported to last as long as 20 to 37 days. Other reports detected viral shedding from upper respiratory samples for up to 12 weeks. According to the CDC, PCR positivity over a 90-day period probably represents prolonged shedding rather than reinfection. However, replication-competent (self-copying) virus can rarely be detected for up to 10 – 20 days, and has often been detected even beyond that in severe Covid-19 cases. This period has been reported to be even longer in immunocompromised patients. In addition to prolonged shedding, 14-17% of discharged patients were described as having repeat positive PCR tests.

Covid-19 Reinfection

A patient in Hong Kong was reported to have an asymptomatic (without symptoms) positive SARS-CoV-2 PCR test 142 days after the first symptomatic (with symptoms) episode of Covid-19. This case was described as a case of SARS-CoV-2 reinfection.

Other possible recurrent cases were also reported in the United States. In these cases, the disease occurred more severely after patients were exposed again at home approximately 2 months after their initial Covid-19 episodes. Genome sequencing detected several potential variations (changes) between the viruses in the separate episodes. The cases were described as reinfections.

Both humoral and cell-mediated immunity are needed to provide protective immunity against SARS-CoV-2 reinfection. It is unknown whether most infected people develop adequate and sustained immune memory responses, such as neutralizing antibodies and memory cells.

Different severity scenarios in Covid-19 disease are illustrated below.

novel coronavirus sars cov 2 covid 19 disease stages when and how transmission occurs antibodies

Long-term studies assessing the persistence of SARS-CoV- and MERS-CoV-specific IgG antibody responses for more than 1 year after infection have found that antibody presence declines over time. However, the presence of antibodies does not necessarily equate to protective immunity, especially if their neutralizing activity is unknown or is known to be low or absent. For SARS-CoV-2 in particular, some earlier studies reported a rapid decline in weakened antibody responses after 90 days. However, a recent study with longer follow-up showed that antibody presence remained stable for 4 months.

Mutating Covid-19

Several different lineages of SARS-CoV-2 with a common ancestor and their subgroups have been identified, with prevalence varying by geographical location. Thousands of distinct variants of the virus, consisting of various mutations including more than 400 variants (changes) in the spike protein, have been reported. It is possible that immune pressure will select new variants that can evade the immune response generated against a previous infection.

NOTE: Variants are mutations that do not change the general identity of the virus. Strains are mutations that give the virus a different identity. In other words, if this happens, everything starts over. Not every nucleotide change in the virus means that it has become different.

It is uncertain whether reinfection may be more severe or milder. A more severe event may occur as a result of antibody-dependent enhancement, or may depend on the severity of the variant / strain and the material used in vaccination. Observing more severe cases may also reflect selection bias toward testing symptomatic cases. A milder course of reinfection has been explained by the initiation of an adaptive immune response during the first episode.

The European CDC proposes a flowchart to assess reinfection in previously confirmed COVID-19 cases; however, the assessment includes tests that are not available, such as whole-genome sequencing and phylogenetic analysis (see the table below for a summary).

Variable

Confirmed reinfection

Clinical reinfection (a)

Epidemiological reinfection

Clinical symptoms

Characteristic clinical symptoms

Characteristic clinical symptoms

Asymptomatic / symptomatic

PCR

(one should be performed)

Positive

Positive

Positive

Viral culture (one should be performed)

Positive

Positive

Positive

Time since the first infection

> 90 days (b)

 

 

Isolation measures

Recommended

Recommended

Recommended

Additional findings

Viral RNA sequencing from both episodes shows different types

Epidemiological risk factor (known exposure or outbreak), no other cause

Epidemiological risk factor (known exposure or outbreak), no other cause

(a) Characteristic clinical symptoms of coronavirus disease 2019 (Covid-19).

(b) May be considered below 90 days if recovery is demonstrated by currently known Covid-19 exposure and two consecutive negative PCR tests.

A Confirmed Diagnosis of SARS-CoV-2 Reinfection Requires

  1. Confirmation of a true first episode – a description of the viral load of the first episode is required. Retesting of the original sample is indicated whenever possible. (Ct values > 35 may indicate possible contamination rather than true infection)
  2. Evidence of reinfection with two positive SARS-CoV-2 RT-PCR tests with Ct >35 at different times. (Or evidence of viral replication through cell culture or detection of subgenomic RNA)
  3. Confirmation of infection with two different phylogenetic strains by high-throughput sequencing consistent with local epidemiology. (Evidence of two different virus variants with any sequence variation between the two episodes)

Note: At least one, and ideally two, negative RT-PCR tests should be documented on two different samples collected between the first and second episodes.

Recurrent Covid-19

  • Relapsing Covid-19 (described in the literature as “recrudescence,” “recurrence,” or “reactivation”) – a clinical relapse of symptoms compatible with Covid-19 – is accompanied by positive / persistent RT-PCR within 90 days of the first infection and is supported by the absence of epidemiological exposure or another cause of the disease.
  • Viral culture may be positive.
  • Demonstrating the same strain through whole-genome sequencing can definitively distinguish this entity from reinfection. Further research is therefore needed to decide whether these cases should be considered for isolation.

Repeat Positive SARS-CoV-2 RT-PCR Tests

  • Repeat SARS-CoV-2 RT-PCR positivity is a positive RT-PCR result after negative tests in an asymptomatic patient within 90 days of the first episode.
  • These cases most likely do not represent replicating (self-copying) viruses and do not require isolation.
  • A low viral load is generally a feature of repeat positivity.

Conclusion

The next few months will probably reveal the extent of reinfections. Fortunately, reinfection appears to be rare so far. More research is needed to provide more precise definitions in terms of the time period, definitions of genetic changes, and serological status.

RELATED TOPICS

Sources

Yahav D., Yelin D., Eckerle I., Eberhardt C. S., Wang J. Cao B. and Kaiser L. (2020, Dec 5). Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clinical Clinical Microbiology and Infection: https://www.clinicalmicrobiologyandinfection.com/ (retrieved)

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Can You Get Coronavirus a Second Time? Other Common Questions

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy